logo

Review Timeline | CrossMark Policy | ClinMed Features
   

Need a supporting hand in manuscript formatting? Write to our team.
Assistance in presubmission | editorialoffice@clinmedjournals.org

     

Original Article 

Clinical Utility of Serum Human Epidermal Growth Factor Receptor Type 2 Testing as a Marker of Therapeutic Response In Tissue HER2-Positive Breast Cancer Patients

Seiichi Mokuyasu and Yasuhiro Suzuki
Abstract

Human Epidermal growth factor Receptor type 2 (HER2) is over expressed in 20.0-30.0% of breast cancers and is currently evaluated histopathologically. Immunohistochemistry and fluorescence in situ hybridization require invasive enucleation of the tumor tissue and may be affected by heterogeneity.

  PDF   |    Full Text

Original Research 

Ipilimumab Activity in Advanced Uveal Melanoma: A Pooled Analysis

Muhammad A Khattak and Elin Gray
Abstract

Uveal Melanoma is a rare tumour that displays different clinical behavior and molecular features compared with cutaneous melanoma. It is generally resistant to systemic therapy and there is no current standard effective therapy to treat patients with advanced disease.

  PDF   |    Full Text

short review article 

Immune Paralysis and the Spontaneous Remission of Cancer

BH Behzad Niakan
Abstract

Once a malignant growth grows past a certain size immune tolerance rather than immune sensitization occurs possibly due to the slow tumor growth. As the malignant grows larger some branches of the immune system (adoptive immunity) become protective of it, while other branches of the immune system oppose its growth.

  PDF   |    Full Text

Research Article 

The Omission of Axillary Lymph Node Dissection in Sentinel Node-Positive Breast Cancer Patients Requires Careful Consideration

Hiroko Nogi, Takashi Kazama, Rei Mimoto, Yoshimi Imawari, Makiko Kamio, Hisashi Shioya, Yasuo Toriumi, Ken Uchida, Masafumi Suzuki and Hiroshi Takeyama
Abstract

Sentinel Node Biopsy (SNB) is used to accurately assess axillary lymph node status in patients with node-negative breast cancer. The purpose of this study was to assess the association between non-sentinel node (SN) metastasis and clinicopathological findings in patients with one or two SN-positive breast cancer.

  PDF   |    Full Text

Review Article 

Bioactive Peptides from Legumes as Anticancer Therapeutic Agents

Gonzalez-Montoya Marcela, Cano-Sampedro Eden and Mora-Escobedo Rosalva
Abstract

Food proteins are a source of nutraceutical and bioactive peptides that promote health and prevent diseases. Legume seed proteins have been widely studied to produce peptides (protein fragments) with a diversity of biological activities.

  PDF   |    Full Text

Research Article 

Validation of Measurement Based Dose Volume Metrics for the Quality Assurance of VMAT Plans

Sankar Arumugam, Aitang Xing, Tony Young, David Thwaites and Lois Holloway
Abstract

Ten each of prostate and head and neck (H&N) VMAT plans were considered for this study. Three types of errors were introduced into the original plans: gantry angle independent and dependent MLC errors, and gantry angle dependent dose error. The percentage difference in PTV-D95 between TPS and 3DVH was compared for no-error and error introduced plans.

  PDF   |    Full Text

Case Report 

A First Case of Male Breast Cancer Responding to Combined Aromatase Inhibitor/Palbociclib Therapy

Steven Sorscher
Abstract

For men with metastatic breast adenocarcinoma standard therapies typically involve the same therapies used for woman. Recently the FDA approved the aromatase inhibitor letrozole combined with the inhibitor of cyclin dependent kinase 4/6 (CDK4/6) palbociclib as first line therapy for women with metastatic breast cancer. Here we report a first case of a man with metastatic breast cancer whose tumor responded to palbociclib and letrozole. This combination might be effective for other men with metastatic breast cancer as well.

  PDF   |    Full Text

Original Article 

Three-Dimensional Ultrasound: Is it Useful for Decision Making in the Management of Rectal Cancer? Is 3D Ultrasound Useful in Rectal Tumor?

Sthela M Murad-Regadas, Romulo M Almeida, Rosilma G Lima Barreto, Doryane MR Lima, Francisco Sergio Pinheiro Regadas, Lusmar Veras Rodrigues, Francisco Coracy C Monteiro, Paulo G Oliveira, Joao Batista Barreto and Univaldo Etsuo Sagae
Abstract

Consecutive patients treated for rectal cancer or adenomas in 4 colorectal centers in Brazil were included. Patients with early-stage rectal cancer identified by 3D-US were assigned to receive resection only, and those with a later stage were assigned to receive CRT. A second 3D-US was performed after CRT to detect the presence of residual tumor and metastatic lymph nodes or complete response.

  PDF   |    Full Text

Original Research Article 

Magnetic Resonance Imaging Targeted Biopsies alone are not Sufficient for Detection of Clinically Significant Prostate Cancer - A Systematic Review and Meta-Analysis

Cayce B Nawaf, Nathanial T Ondeck, Laura A Skrip, Rollin K Say, John M Gunselman, Jamil Syed, Peter G Schulam and Preston C Sprenkle
Abstract

Magnetic resonance imaging targeted biopsies (MRI-Tbx) has the potential to detect significant prostate cancer with a small number of cores; however, there are concerns that some clinically significant (CS) cancers may not be visible on MRI or identified with targeted biopsies alone.

  PDF   |    Full Text